Assignee
NGUYEN MARK QUANG
US·16 granted patents·13 pending applications·39 citations·filing 2013–2017
Top patents by PatentIndex Score
29 records- 0195US9295731B2Cleavable drug conjugates, compositions thereof and methods of useNGUYEN MARK QUANG·Filed 2013·Granted Mar 29, 2016·16 cites·10 claims
- 0292US9532968B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Jan 3, 2017·6 cites·19 claims
- 0392US9409872B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Aug 9, 2016·6 cites·13 claims
- 0490US9394312B1Ibrutinib prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Jul 19, 2016·4 cites·14 claims
- 0586US9630918B2Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Apr 25, 2017·2 cites·20 claims
- 0681US9630917B2Cysteamine prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Apr 25, 2017·2 cites·16 claims
- 0780US9963428B1Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2017·Granted May 8, 2018·1 cites·17 claims
- 0877US9701656B2Tiopronin prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Jul 11, 2017·1 cites·18 claims
- 0972US9403784B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Aug 2, 2016·1 cites·20 claims
- 1064US10898503B2Cleavable drug conjugates, compositions thereof and methods of useNGUYEN MARK QUANG·Filed 2016·Granted Jan 26, 2021·0 cites·3 claims
- 1159US2016143937A1Methods of using cleavable drug conjugates and compositions thereofNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 1258US9925191B2Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Granted Mar 27, 2018·0 cites·22 claims
- 1355US9598354B2Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Mar 21, 2017·0 cites·7 claims
- 1453US2016361315A1Ibrutinib prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 1552US2017027898A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 1649US9738620B2Trientine prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Aug 22, 2017·0 cites·20 claims
- 1746US9695189B2Chemical crosslinkers and compositions thereofNGUYEN MARK QUANG·Filed 2013·Granted Jul 4, 2017·0 cites·9 claims
- 1844US9597306B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Mar 21, 2017·0 cites·19 claims
- 1944US2016297770A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 2043US9630934B2Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Apr 25, 2017·0 cites·19 claims
- 2142US2017022153A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2242US2017022149A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2342US2017008834A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2442US2017020837A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2541US2017001952A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2641US2017001953A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2737US2017022147A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2836US2017008835A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 2935US2016355464A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NGUYEN MARK QUANG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →